Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Financial Results:
Torrent Pharmaceuticals Ltd reported Revenues for Q2FY25 of ₹2,889.00 Crores up from ₹2,660.00 Crore year on year, a rise of 8.61%.
Total Expenses for Q2FY25 of ₹2,212.00 Crores up from ₹2,127.00 Crores year on year, a rise of 4.0%.
Consolidated Net Profit of ₹453.00 Crores up 17.36% from ₹386.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹13.39, up 17.35% from ₹11.41 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.